Impact Factor 4.400

The 1st most cited open-access journal in Pharmacology & Pharmacy

General Commentary ARTICLE

Front. Pharmacol., 15 June 2016 | https://doi.org/10.3389/fphar.2016.00190

Expression of Concern: Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells

  • Frontiers, Lausanne, Switzerland

An expression of concern on
Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells

by Samie, N., Haerian, B. S., Muniandy, S., Marlina, A., Kanthimathi, M. S., Abdullah, N. B., et al. (2016). Front. Pharmacol. 6:313. doi: 10.3389/fphar.2015.00313

With this notice, Frontiers states its awareness of serious allegations surrounding the article “Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells” published on 28 January 2016. Our Chief Editors, Prof. Theophile Godfraind and Prof. Olivier Feron, will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.

Citation: Frontiers Editorial Office (2016) Expression of Concern: Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells. Front. Pharmacol. 7:190. doi: 10.3389/fphar.2016.00190

Received: 14 June 2016; Accepted: 14 June 2016;
Published: 15 June 2016.

Edited and reviewed by: Théophile Godfraind, Université Catholique de Louvain, Belgium

Copyright © 2016 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org